Managing Ocular Surface Disease - Report - MDSpire

Managing Ocular Surface Disease

  • By

  • FRANK W. BOWDEN III, MD, FACS

  • October 1, 2025

  • 6 min

Share

Clinical Report: Managing Ocular Surface Disease

Overview

Ocular surface disease (OSD) is a prevalent condition affecting patient comfort and visual outcomes, often with poor correlation between symptoms and clinical findings. Improved diagnostic technologies and a systematic approach to management can enhance treatment efficacy and patient satisfaction.

Background

OSD is the most common reason for office visits among eyecare professionals, significantly impacting patient quality of life and treatment outcomes. The condition can lead to complications in contact lens wear and ocular surgeries, necessitating a comprehensive understanding of its pathophysiology. Recent advancements in diagnostic tools and therapeutic strategies are crucial for effective management of this multifaceted disorder.

Data Highlights

Remove placeholder text and summarize key findings or data from the source material.

Key Findings

  • OSD often presents with significant clinical pathology despite minimal symptoms.
  • Diagnostic technologies such as tear film hyperosmolarity tests and meibomian gland imaging enhance detection and management.
  • Effective management requires a systematic diagnostic approach and targeted therapeutic interventions.
  • Patient education is vital for improving compliance and treatment outcomes.
  • Chronic conditions like dry eye disease are prevalent among OSD patients, necessitating tailored management strategies.

Clinical Implications

Clinicians should prioritize a detailed ocular history and utilize advanced diagnostic tools to identify OSD effectively. Educating patients about their condition and treatment options can improve adherence to management plans and enhance overall satisfaction with eyecare services.

Conclusion

A comprehensive understanding of OSD and its management can significantly improve patient outcomes and satisfaction. Ongoing education and the use of innovative diagnostic tools are essential for eyecare professionals.

References

  1. Voicu L, Salim S, FACS, Glaucoma Physician, 2023 -- Treatment of Severe Ocular Surface Disease in the Glaucoma Patient
  2. Ophthalmology Management, 2025 -- Mitigating Ocular Surface Disease in Patients With Glaucoma
  3. Dougal J, Contact Lens Spectrum, 2006 -- Managing Ocular Surface Irritation in a Busy Specialty Practice
  4. Ophthalmology Management, 2018 -- The Role of MIGS to Manage Glaucoma in the Dry Eye Patient
  5. TFOS DEWS III: Diagnostic Methodology, ScienceDirect, 2025 -- Diagnostic Methodology
  6. PubMed, 2023 -- Perfluorohexyloctane ophthalmic solution for dry eye disease: pooled analysis of two phase 3 clinical trials
  7. PubMed, 2023 -- Effectiveness and safety of intense pulsed light therapy for dry eye symptoms due to meibomian gland dysfunction-A systematic review and meta-analysis
  8. TFOS DEWS III: Diagnostic Methodology - ScienceDirect
  9. Perfluorohexyloctane ophthalmic solution for dry eye disease: pooled analysis of two phase 3 clinical trials - PubMed
  10. Effectiveness and safety of intense pulsed light therapy for dry eye symptoms due to meibomian gland dysfunction-A systematic review and meta-analysis - PubMed

Original Source(s)

Related Content